CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
REVENUES:
Total revenues	$ 150,349	$ 111,700	$ 79,565
COST OF REVENUES:
Total cost of revenues	47,100	31,845	21,358
Gross profit	103,249	79,855	58,207
OPERATING EXPENSES:
General and administrative	68,764	150,614	35,888
Sales and marketing	29,286	51,725	9,927
Technology and development	17,163	153,400	6,318
Total operating expenses	115,213	355,739	52,133
Income (loss) from operations	(11,964)	(275,884)	6,074
NON-OPERATING (EXPENSE) INCOME:
Interest income (expense) net	413	(4,594)	(1,662)
Other (expense) income	(638)	(1,185)	82
Total non-operating expense	(225)	(5,779)	(1,580)
Income (loss) before income taxes	(12,189)	(281,663)	4,494
Income taxes	1,074	579	433
Net income (loss)	(13,263)	(282,242)	4,061
Net income (loss) attributable to non-controlling interests	(5,609)	(123,925)
Net income (loss) attributable to Enfusion, Inc.	$ (7,654)	$ (158,317)	4,061
Loss per Class A common share attributable to Enfusion, Inc.:
Loss per Class A common share attributable to Enfusion, Inc., Basic	$ (0.10)	$ (2.26)
Loss per Class A common share attributable to Enfusion, Inc., Diluted	$ (0.10)	$ (2.26)
Weighted Average number of Class A common shares outstanding:
Weighted Average number of Class A common shares outstanding, Basic	85,393	83,045
Weighted Average number of Class A common shares outstanding, Diluted	85,393	83,045
Platform subscriptions
REVENUES:
Total revenues	$ 138,868	$ 103,259	73,550
COST OF REVENUES:
Total cost of revenues	40,017	27,195	18,015
Managed services
REVENUES:
Total revenues	9,821	7,119	4,436
COST OF REVENUES:
Total cost of revenues	6,692	4,425	2,512
Other
REVENUES:
Total revenues	1,660	1,322	1,579
COST OF REVENUES:
Total cost of revenues	$ 391	$ 225	$ 831